DCAT Value Chain Insights

Big Pharma Strategies and Growth Initiatives: What's In Store for 2020

At the J.P. Morgan Annual Healthcare Conference in San Francisco this week, pharma industry executives highlighted their companies' strategies and key growth initiatives. What is the latest from...

20-20 Insights and Outlook on the CDMO Market

The stars are aligned for another strong year of performance for CDMOs. DCAT Value Chain Insights examines industry fundamentals and an outlook for pharma outsourcing in 2020. Strong fundamentals...

Digital Transformation in 2020: What Should Pharma Know?

Information
January 6, 2020
Sponsored by LabVantage

To extract continuous value from R&D activities and ensure manufacturing quality, pharmaceutical companies are – or should be – embracing digital transformation. This business journey uses...

Read More
A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More